Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
NCT ID: NCT03847441
Last Updated: 2019-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2017-10-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata
NCT01559584
Intralesional Vitamin D in Alopecia Areata
NCT04660786
Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma
NCT05954104
Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areata
NCT04003376
Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids
NCT05017454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I
Calcipotriol
Calcipotriol ointment (0.005%)
vitamin D3 level
vitamin D3 (ng/ml)
Group II
Narrow Band UVB
NB-UVB (311nm) phototherapy
vitamin D3 level
vitamin D3 (ng/ml)
Group III
Calcipotriol
Calcipotriol ointment (0.005%)
Narrow Band UVB
NB-UVB (311nm) phototherapy
vitamin D3 level
vitamin D3 (ng/ml)
Group IV
vitamin D3 level
vitamin D3 (ng/ml)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Calcipotriol
Calcipotriol ointment (0.005%)
Narrow Band UVB
NB-UVB (311nm) phototherapy
vitamin D3 level
vitamin D3 (ng/ml)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
14 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aswan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Moustafa A. El Taieb
Head of Dermatology, Venereology and Andrology Department, Ass. Prof. Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan University Hospital
Aswān, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Alopecia Calcipotiol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.